236 related articles for article (PubMed ID: 24931193)
1. Constitutive activities in the thyrotropin receptor: regulation and significance.
Kleinau G; Biebermann H
Adv Pharmacol; 2014; 70():81-119. PubMed ID: 24931193
[TBL] [Abstract][Full Text] [Related]
2. Thyroid-stimulating hormone and thyroid-stimulating hormone receptor structure-function relationships.
Szkudlinski MW; Fremont V; Ronin C; Weintraub BD
Physiol Rev; 2002 Apr; 82(2):473-502. PubMed ID: 11917095
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the mouse TSH receptor equivalent to human constitutively activating TSH receptor mutations also cause constitutive activity.
Neumann S; Krohn K; Chey S; Paschke R
Horm Metab Res; 2001 May; 33(5):263-9. PubMed ID: 11440271
[TBL] [Abstract][Full Text] [Related]
4. New pathogenic thyrotropin receptor mutations decipher differentiated activity switching at a conserved helix 6 motif of family A GPCR.
Biebermann H; Winkler F; Handke D; Teichmann A; Gerling B; Cameron F; Eichhorst J; Grüters A; Wiesner B; Kühnen P; Krude H; Kleinau G
J Clin Endocrinol Metab; 2012 Feb; 97(2):E228-32. PubMed ID: 22112806
[TBL] [Abstract][Full Text] [Related]
5. Identification and evaluation of constitutively active thyroid stimulating hormone receptor mutations.
Lado-Abeal J; Quisenberry LR; Castro-Piedras I
Methods Enzymol; 2010; 484():375-95. PubMed ID: 21036242
[TBL] [Abstract][Full Text] [Related]
6. Controversial constitutive TSHR activity: patients, physiology, and in vitro characterization.
Huth S; Jaeschke H; Schaarschmidt J; Paschke R
Horm Metab Res; 2014 Jun; 46(7):453-61. PubMed ID: 24845969
[TBL] [Abstract][Full Text] [Related]
7. Thyrotropin receptor mutations as a tool to understand thyrotropin receptor action.
Wonerow P; Neumann S; Gudermann T; Paschke R
J Mol Med (Berl); 2001 Dec; 79(12):707-21. PubMed ID: 11862314
[TBL] [Abstract][Full Text] [Related]
8. Shared sporadic and somatic thyrotropin receptor mutations display more active in vitro activities than familial thyrotropin receptor mutations.
Lueblinghoff J; Eszlinger M; Jaeschke H; Mueller S; Bircan R; Gozu H; Sancak S; Akalin S; Paschke R
Thyroid; 2011 Mar; 21(3):221-9. PubMed ID: 21190443
[TBL] [Abstract][Full Text] [Related]
9. TSH receptor monoclonal antibodies with agonist, antagonist, and inverse agonist activities.
Sanders J; Miguel RN; Furmaniak J; Smith BR
Methods Enzymol; 2010; 485():393-420. PubMed ID: 21050929
[TBL] [Abstract][Full Text] [Related]
10. Comparative proteomic analysis to dissect differences in signal transduction in activating TSH receptor mutations in the thyroid.
Krause K; Boisnard A; Ihling C; Ludgate M; Eszlinger M; Krohn K; Sinz A; Fuhrer D
Int J Biochem Cell Biol; 2012 Feb; 44(2):290-301. PubMed ID: 22074661
[TBL] [Abstract][Full Text] [Related]
11. Identification and functional characterization of two novel activating thyrotropin receptor mutants in toxic thyroid follicular adenomas.
Castro I; Lima L; Seoane R; Lado-Abeal J
Thyroid; 2009 Jun; 19(6):645-9. PubMed ID: 19499991
[TBL] [Abstract][Full Text] [Related]
12. Proper targeting and activity of a nonfunctioning thyroid-stimulating hormone receptor (TSHr) combining an inactivating and activating TSHr mutation in one receptor.
Agretti P; De Marco G; Collecchi P; Chiovato L; Vitti P; Pinchera A; Tonacchera M
Eur J Biochem; 2003 Sep; 270(18):3839-47. PubMed ID: 12950268
[TBL] [Abstract][Full Text] [Related]
13. A familial thyrotropin (TSH) receptor mutation provides in vivo evidence that the inositol phosphates/Ca2+ cascade mediates TSH action on thyroid hormone synthesis.
Grasberger H; Van Sande J; Hag-Dahood Mahameed A; Tenenbaum-Rakover Y; Refetoff S
J Clin Endocrinol Metab; 2007 Jul; 92(7):2816-20. PubMed ID: 17456567
[TBL] [Abstract][Full Text] [Related]
14. A new phenotype of nongoitrous and nonautoimmune hyperthyroidism caused by a heterozygous thyrotropin receptor mutation in transmembrane helix 6.
Winkler F; Kleinau G; Tarnow P; Rediger A; Grohmann L; Gaetjens I; Krause G; L'Allemand D; Grüters A; Krude H; Biebermann H
J Clin Endocrinol Metab; 2010 Aug; 95(8):3605-10. PubMed ID: 20501679
[TBL] [Abstract][Full Text] [Related]
15. Current standards, variations, and pitfalls for the determination of constitutive TSHR activity in vitro.
Mueller S; Jaeschke H; Paschke R
Methods Enzymol; 2010; 485():421-36. PubMed ID: 21050930
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic potential of a mutant human thyrotropin receptor expressed in FRTL-5 cells.
Fournes B; Monier R; Michiels F; Milgrom E; Misrahi M; Feunteun J
Oncogene; 1998 Feb; 16(8):985-90. PubMed ID: 9519872
[TBL] [Abstract][Full Text] [Related]
17. Lack of in vitro constitutive activity for four previously reported TSH receptor mutations identified in patients with nonautoimmune hyperthyroidism and hot thyroid carcinomas.
Jaeschke H; Mueller S; Eszlinger M; Paschke R
Clin Endocrinol (Oxf); 2010 Dec; 73(6):815-20. PubMed ID: 20846293
[TBL] [Abstract][Full Text] [Related]
18. Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance.
Calebiro D; de Filippis T; Lucchi S; Covino C; Panigone S; Beck-Peccoz P; Dunlap D; Persani L
Hum Mol Genet; 2005 Oct; 14(20):2991-3002. PubMed ID: 16135555
[TBL] [Abstract][Full Text] [Related]
19. Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules.
Führer D; Holzapfel HP; Wonerow P; Scherbaum WA; Paschke R
J Clin Endocrinol Metab; 1997 Nov; 82(11):3885-91. PubMed ID: 9360556
[TBL] [Abstract][Full Text] [Related]
20. The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: implications for hormone-receptor interaction and antagonist design.
Zhang M; Tong KP; Fremont V; Chen J; Narayan P; Puett D; Weintraub BD; Szkudlinski MW
Endocrinology; 2000 Sep; 141(9):3514-7. PubMed ID: 10965926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
